SCHEMBL7322209

SCHEMBL7322209

CCOC(=O)c1ccc(CNC(=O)O)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.73
SMN1; SMN2 Q16637 3/20 0.71
MAPT P10636 3/20 0.65
NAMPT P43490 3/20 0.65
KMT2A Q03164 5/20 0.62
MEN1 O00255 4/20 0.62
LMNA P02545 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
MAOA P21397 1/20 0.61
L3MBTL1 Q9Y468 3/20 0.60
GAA P10253 2/20 0.58
CA12 O43570 2/20 0.58
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
CA7 P43166 2/20 0.58
ESR1 P03372 1/20 0.58
CA9 Q16790 1/20 0.58
ESR2 Q92731 1/20 0.58
CA14 Q9ULX7 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9125949 0.88 HTT (0.67) HTTSMN1; SMN2MAPTNAMPTKMT2A
SCHEMBL8139902 0.87 HTT (0.65) HTTSMN1; SMN2MAPTNAMPTKMT2A
SCHEMBL11988605 0.84 SMN1; SMN2 (0.69) HTTSMN1; SMN2MAPTNAMPTKMT2A
SCHEMBL2940862 0.83 SMN1; SMN2 (0.77) HTTSMN1; SMN2MAPTNAMPTKMT2A
SCHEMBL28120177 0.83 SMN1; SMN2 (0.67) HTTSMN1; SMN2MAPTNAMPTKMT2A
SCHEMBL25232330 0.83 SMN1; SMN2 (0.77) HTTSMN1; SMN2MAPTNAMPTKMT2A
SCHEMBL3905352 0.82 HTT (0.59) HTTSMN1; SMN2MAPTNAMPTKMT2A
SCHEMBL22501702 0.81 HTT (0.51) HTTSMN1; SMN2MAPTNAMPTKMT2A
SCHEMBL128190 0.81 CA1 (0.70) HTTSMN1; SMN2MAPTKMT2AMEN1
SCHEMBL5932688 0.81 CYP1A2 (0.55) HTTSMN1; SMN2KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103720-A ENZYME INHIBITORS; ANTIICHEMIC AND -TUMOR AGENTS; STROKES; ALZEIMER'S DISEASE BASF AKTIENGESELLSCHAFT (DE) 2000-08-15 US disclosed
CN-1245486-A Ketobenzamides as calpain inhibitors BASF AG (DE) 2000-02-23 CN disclosed